The Trustees of Chordoma UK invite you to a 'Meet the Experts' evening
Event Information
About this Event
We would like to invite all patients with chordoma to attend a special “Meet the Experts” evening, hosted by Professor Adrienne Flanagan at the University College London Cancer Institute. Attendees will have the opportunity to hear from clinicians and scientists, with experience and expert knowledge of chordoma, and find out more about the treatment of chordoma and the research that is being undertaken.
Short presentations will be given by the individuals listed below. You will have the opportunity to chat to the speakers and other guests, and to the visit the laboratories and have a flavour of the ‘science in action’ that is taking place by speaking to those doing the research.
Speakers:
Professor Adrienne Flanagan
Adrienne is Head of Academic Pathology at UCL Cancer Institute. Adrienne’s research focuses on identifying genetic alterations involved in the development and progression of bone tumours and translating these findings into clinical practice. Adrienne discovered that brachyury expression is the hallmark of chordoma, a biomarker which is now employed universally in the diagnosis of chordoma. Her work contributed in a major way to the recent “Afatinib in locally advanced and metastatic chordoma” Clinical Trial that has opened in the UK.
Dr Beatrice Seddon
Beatrice is the Lead Sarcoma Consultant Clinical Oncologist at University College London Hospital and London Sarcoma Service specialising exclusively in the management (chemotherapy and radiotherapy) of soft tissue and bone sarcomas. She is a member of the British Sarcoma Group and has co-authored guidelines on the management of chordomas.
Mr Craig Gerrand
Craig is a Consultant Orthopaedic Surgeon and the Cancer Lead at the Royal National Orthopaedic Hospital. His research interests include the surgical aspects of sarcoma care, survivorship, and surgical outcomes. He sits on the board of the British Sarcoma Group and co-authored guidelines on the management of sarcomas.
Professor David Choi
David is a Consultant Neurosurgeon at the National Hospital for Neurology and Neurosurgery. His clinical and research interests include complex spine surgery and spinal tumours such as chordomas. He has authored several publications on chordoma in peer-reviewed journals.
Dr Sandra Strauss
Sandra is a Medical Oncologist at University College London Hospital and her clinical practice is exclusively in the treatment sarcomas. Sandra is the principal investigator for the “Afatinib in locally advanced and metastatic chordoma”, and is a member of the National Cancer Research Institute Clinical Studies Group for sarcoma and bone subgroup, as well as the EORTC Soft Tissue and Bone Sarcoma Group.